Heart valve disease affects more than 5 million Americans, and roughly 100,000 valve replacements are performed each year in the United States. The introduction of transcatheter aortic valve replacement (TAVR) has expanded who can be treated, particularly older adults previously considered too high-risk for surgery — and, more recently, many patients at lower surgical risk as well. Heart valve replacement can be performed through traditional open-heart surgery (surgical aortic valve replacement, or SAVR) or, for selected aortic valves, through a catheter-based approach (TAVR) with no chest incision. The decision between surgical and transcatheter replacement, and between mechanical and tissue valves, has long-term implications. This guide explains the options, the procedure, and what recovery looks like. It is general information, not medical advice — your cardiologist and surgeon decide what is right for you, and figures here are estimates that vary.
What Heart Valve Replacement Is and Who Needs It
The heart has four valves: aortic, mitral, pulmonary, and tricuspid. Replacement is most commonly performed on the aortic and mitral valves. Aortic stenosis (a narrowed valve) and aortic regurgitation (a leaky valve) are the most common indications. Mitral regurgitation is sometimes repaired rather than replaced, and repair is generally preferred when feasible because it preserves the native valve and avoids long-term anticoagulation in many cases.
Per the American Heart Association and the ACC/AHA valvular heart disease guideline, indications include severe symptomatic valve disease (chest pain, shortness of breath, fainting, heart failure), severe disease with reduced left-ventricular function, and selected patients who meet specific criteria even before symptoms appear. The details of who qualifies — and when — are nuanced and are set by current guidelines, so this is a conversation for your cardiologist rather than a checklist to apply yourself. Most patients have undergone echocardiography and, in many cases, a cardiac catheterization beforehand. For broader cardiovascular background, see our Medical Conditions guide.
How the Procedure Is Performed: SAVR vs TAVR
Surgical valve replacement (SAVR) is performed under general anesthesia through a sternotomy or, in selected cases, a smaller minimally invasive incision. The heart is stopped temporarily and circulation is supported by a heart-lung bypass machine. The diseased valve is removed and a new valve (mechanical or tissue) is sewn in place. The procedure commonly takes about three to five hours.
TAVR is performed through a catheter, usually inserted through the femoral artery in the groin. A collapsed replacement valve mounted on a balloon or a self-expanding frame is positioned across the diseased aortic valve and deployed inside it. The procedure often takes about one to two hours. The Cleveland Clinic and current FDA labeling note that TAVR is approved across the surgical-risk spectrum — high, intermediate, and low risk — after landmark trials extended it to lower-risk patients; research into using it even earlier (for example in some patients with severe but not-yet-symptomatic aortic stenosis) has continued to evolve, so ask your team about the latest evidence for your situation. Mitral-valve interventions include surgical replacement, surgical repair, transcatheter edge-to-edge repair (such as MitraClip), and emerging transcatheter mitral valve replacement.
Preparation and What to Expect on the Day
Preoperative preparation commonly includes echocardiography, cardiac CT (especially before TAVR for valve sizing), coronary angiography, lung-function testing, and dental clearance. A multidisciplinary “heart-valve team” reviews each case to determine the optimal approach, and this shared, team-based decision is considered the standard of care. Smoking cessation, blood-sugar optimization, and dental work to eliminate infection sources are important before surgery. Antibiotics are given around the time of the procedure.
On the day, expect to arrive at the hospital early. Surgical valve replacement typically requires about four to seven days of hospitalization. TAVR patients commonly stay one to three days, and some low-risk patients go home even sooner. The first day or two after open surgery are usually in the ICU. Walking generally begins on day one. Pain control evolves from IV to oral medications. Most patients are discharged once they tolerate food, walk independently, and have stable vital signs.
Recovery Timeline and Rehab
Surgical valve replacement recovery follows the same general arc as coronary bypass surgery: sternal precautions for roughly six weeks, return to desk work at about six to 12 weeks, and return to physical labor at around three to four months. Cardiac rehabilitation is recommended for nearly all patients and improves long-term outcomes substantially. Exact timelines vary with your baseline health and any complications, so follow your team’s specific instructions rather than a generic calendar.
TAVR recovery is usually much faster. Many patients walk the day of the procedure, leave the hospital within one to three days, and return to most activities within one to two weeks. The femoral access site typically requires several days of restricted heavy lifting. Many TAVR patients describe feeling better quickly because the obstruction has been relieved. Long-term follow-up includes echocardiography and attention to endocarditis prevention (including good dental hygiene and, when indicated, antibiotic prophylaxis before certain procedures). The NHLBI emphasizes lifelong cardiology follow-up regardless of approach.
Risks, Complications, and Outcomes
Surgical valve replacement carries operative risk. Reported mortality is roughly 2 to 5 percent for elective primary aortic or mitral replacement at experienced centers and higher for redo or combined procedures. TAVR mortality is roughly 1 to 3 percent in current registries. Risks include stroke (about 2 to 4 percent surgical, 2 to 3 percent TAVR), the need for a permanent pacemaker (roughly 5 to 10 percent after surgical aortic replacement and higher — often 10 to 20 percent — after TAVR, though newer valves and techniques have lowered this at some centers), atrial fibrillation, bleeding, infection, paravalvular leak (more common with TAVR), and structural valve deterioration over time. These are population estimates; your individual risk depends on your anatomy, age, and other conditions, and your team can give you a personalized figure.
When to seek emergency care: Call 911 or go to the nearest emergency room if you experience sudden chest pain or pressure, severe shortness of breath, signs of stroke (facial droop, arm weakness, speech difficulty — remember FAST), heavy bleeding from incisions or access sites, fever above about 101°F with sternal or access-site drainage, sudden palpitations with lightheadedness, calf swelling and pain (possible DVT), or sudden severe back or abdominal pain.
Mechanical vs Tissue Valves
The choice between mechanical and tissue (bioprosthetic) valves is one of the most important decisions before surgery. As MedlinePlus summarizes, mechanical valves are highly durable and often last a lifetime, but they require lifelong blood-thinning medicine (warfarin) to prevent clots on the valve. Tissue valves typically do not require long-term anticoagulation, but they wear out over time and may need replacement after roughly 10 to 20 years (some sources cite about 12 to 15 years, and durability depends on valve type and patient age). Younger patients were historically steered toward mechanical valves for durability, although practice has shifted toward tissue valves in many cases, partly because a worn tissue valve can sometimes be treated later with a valve-in-valve TAVR.
Patient preference, age, lifestyle, pregnancy plans, and bleeding risk all factor into the decision. Patients already on warfarin for another reason may favor a mechanical valve; active patients and women who may become pregnant often prefer a tissue valve (warfarin poses risks in pregnancy). This is genuinely a shared decision to be made jointly with your cardiologist and surgeon — there is no single right answer for everyone. Patients weighing valve options alongside rhythm problems may also find our cardiac ablation and pacemaker implantation guides useful for context.
Cost Considerations
Costs vary enormously by hospital, region, valve type, and insurance, so treat every figure here as a rough estimate and request an itemized quote. Surgical valve replacement billed charges commonly range from about $80,000 to $250,000 without insurance. TAVR billed charges often run about $50,000 to $200,000. Medicare payments (which are far lower than billed charges) have historically averaged in the tens of thousands for either approach. Insured out-of-pocket costs commonly land in the range of a few thousand to around $10,000 after deductibles and coinsurance, depending on your plan. The valve device itself accounts for a meaningful share of the total. For broader cost-shopping advice, see our healthcare costs guide.
Frequently Asked Questions
TAVR vs surgical aortic valve replacement: which is better?
There is no universal answer. For higher-risk patients, TAVR is often preferred. For low- and intermediate-risk patients, both are reasonable options, with TAVR offering faster recovery and surgery offering a longer track record for valve durability and the ability to address other problems in the same operation. The heart-valve team makes a personalized recommendation based on your anatomy, age, and other conditions.
How long does a tissue valve last?
Estimates commonly range from about 10 to 20 years, and some sources cite roughly 12 to 15 years; younger patients tend to wear out valves faster. Mechanical valves typically last a lifetime but require lifelong warfarin. Many teams now favor tissue valves in a broader range of patients, partly because a future valve-in-valve TAVR may be an option when a tissue valve wears out.
How long is recovery from valve replacement?
Surgical: hospital stay of about four to seven days, sternal precautions for roughly six weeks, and return to work in about six to 12 weeks. TAVR: hospital stay of one to three days and return to most activities in about one to two weeks. Cardiac rehabilitation is recommended after both. Your own timeline depends on your health and recovery.
Will I need blood thinners after valve replacement?
Mechanical valves require lifelong warfarin. Tissue valves often require a shorter course of anticoagulation followed by aspirin, though protocols vary. After TAVR, antiplatelet or anticoagulant regimens are individualized. Never start, stop, or change these medicines on your own — follow your cardiologist’s instructions, because getting anticoagulation wrong can be dangerous.
Is TAVR available for younger, lower-risk patients?
TAVR is now approved across the surgical-risk spectrum, including many lower-risk patients, and the evidence base continues to grow. However, durability data over very long time frames is still maturing, so for younger patients the choice between TAVR and surgery involves weighing lifetime management — a decision best made with your heart-valve team.
What to Discuss With Your Cardiologist and Surgeon
Heart valve replacement is a major intervention with excellent long-term outcomes when properly performed. Bring questions about TAVR versus surgical eligibility, mechanical versus tissue valve choice, the surgeon’s or proceduralist’s annual volume, the expected pacemaker rate at that center, and the rehabilitation plan. A multidisciplinary heart-valve team review at a high-volume center is considered the gold standard for complex cases. After replacement, lifelong cardiology follow-up, endocarditis prevention, and (depending on valve type) anticoagulation management are essential to preserving the result. Use this page to prepare good questions — not to make the decision on your own.
Medical disclaimer: This article is for general informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Whether to replace a heart valve, whether to use a surgical or transcatheter approach, and whether to choose a mechanical or tissue valve are individualized decisions made with a qualified cardiologist and cardiac surgeon (a heart-valve team). Anticoagulation must be managed by your clinicians — do not start or stop blood thinners on your own. Timelines, risks, and costs vary and the figures here are estimates. Call 911 for acute symptoms such as chest pain, severe shortness of breath, or signs of stroke.
Sources
- American Heart Association — heart valve disease, treatment options, and endocarditis prevention
- 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease — indications, risk-based approach, and valve selection
- MedlinePlus — heart valve surgery; mechanical vs biological (tissue) valves and anticoagulation
- National Heart, Lung, and Blood Institute (NHLBI) — heart valve diseases and lifelong follow-up
- Cleveland Clinic / Mayo Clinic — TAVR eligibility across the risk spectrum and recovery expectations